Prestige Consumer Healthcare (PBH) Other Non-Current Liabilities (2013 - 2025)

Prestige Consumer Healthcare (PBH) recorded quarterly Other Non-Current Liabilities of $5.7 million in Q4 2025, up 6.84% quarter-over-quarter from $5.4 million in Q3 2025, and up 14.28% on a YoY basis from $5.0 million in Q4 2024.

Prestige Consumer Healthcare (PBH) Other Non-Current Liabilities (2013 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Other Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $5.7 million for Q4 2025.

  • In Q4 2025, Other Non-Current Liabilities rose 14.28% year-over-year to $5.7 million; the TTM figure through Dec 2025 stood at $5.7 million (up 14.28% YoY), while the FY2025 annual figure was $5.4 million, down 41.31% from the prior year.
  • Other Non-Current Liabilities was $5.7 million for Q4 2025 at Prestige Consumer Healthcare, up from $5.4 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $9.2 million in Q1 2024 to a low of $5.0 million in Q4 2024.
  • Historically, Other Non-Current Liabilities has averaged $7.4 million across 5 years, with a median of $8.3 million in 2021.
  • The sharpest annual moves came in 2021 and 2025: Other Non-Current Liabilities slumped 66.15% in 2021, then rose 14.28% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $8.4 million in 2021, then rose by 5.21% to $8.9 million in 2022, then rose by 0.53% to $8.9 million in 2023, then tumbled by 43.61% to $5.0 million in 2024, then grew by 14.28% to $5.7 million in 2025.
  • The last three Other Non-Current Liabilities figures came in at $5.7 million (Q4 2025), $5.4 million (Q3 2025), and $5.4 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Prestige Consumer Healthcare 2.37 Bn 2.31 Bn 157.37 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 5.75 Mn
Sep 30, 2025 5.38 Mn
Jun 30, 2025 5.41 Mn
Mar 31, 2025 5.39 Mn
Dec 31, 2024 5.03 Mn
Sep 30, 2024 5.12 Mn
Jun 30, 2024 5.14 Mn
Mar 31, 2024 9.19 Mn
Dec 31, 2023 8.92 Mn
Sep 30, 2023 8.90 Mn
Jun 30, 2023 8.18 Mn
Mar 31, 2023 8.17 Mn
Dec 31, 2022 8.87 Mn
Sep 30, 2022 8.88 Mn
Jun 30, 2022 8.92 Mn
Mar 31, 2022 7.48 Mn
Dec 31, 2021 8.43 Mn
Sep 30, 2021 8.49 Mn
Jun 30, 2021 8.56 Mn
Mar 31, 2021 8.61 Mn